Pharmacogenetic Study in Castration-resistant Prostate Cancer Patients Treated With Abiraterone Acetate
NACompletedINTERVENTIONAL
Enrollment
148
Participants
Timeline
Start Date
April 30, 2013
Primary Completion Date
September 6, 2020
Study Completion Date
December 3, 2020
Conditions
Pharmacogenetic Study
Interventions
DRUG
Abiraterone Acetate
Trial Locations (1)
06000
Centre Antoine Lacassagne, Nice
All Listed Sponsors
lead
Centre Antoine Lacassagne
OTHER
NCT01858441 - Pharmacogenetic Study in Castration-resistant Prostate Cancer Patients Treated With Abiraterone Acetate | Biotech Hunter | Biotech Hunter